Can BUN be elevated without kidney disease?

Yes. Volume depletion, high-protein diet, gastrointestinal bleeding, fever, and corticosteroid use all raise BUN through increased production or enhanced tubular reabsorption, even when glomerular filtration is normal. The BUN:creatinine ratio and clinical context help distinguish these from true renal impairment.

Is fasting required for a BUN test?

No. BUN does not require fasting, though it is often drawn as part of a metabolic panel that may specify fasting for glucose and lipids. Recent high-protein meals can modestly elevate the result.

What does a low BUN mean?

Low BUN is usually benign and occurs with overhydration, low dietary protein, malnutrition, or severe liver disease (impaired urea synthesis). It is seen in pregnancy and SIADH and rarely indicates pathology unless liver function is severely compromised.

Why is the BUN:creatinine ratio important?

The ratio localises the cause of azotaemia. A ratio above 20:1 suggests prerenal azotaemia (volume depletion, reduced renal perfusion), while a ratio of 10–15:1 points to intrinsic renal disease. Gastrointestinal bleeding often pushes the ratio above 30:1.

Does hydration status affect BUN?

Yes, substantially. Dehydration reduces renal perfusion and slows tubular flow, raising BUN disproportionately to creatinine. Overhydration dilutes BUN and increases its clearance. Practitioners assess hydration and volume status when interpreting the result.

How long do BUN results take?

Results are typically available within 2–3 business days from specimen receipt at Boston Heart Diagnostics.

Can BUN be normal in someone with kidney disease?

Yes, in early or compensated chronic kidney disease, particularly when dietary protein is low or the patient is well hydrated. BUN should be interpreted alongside creatinine, estimated GFR, and urinalysis rather than in isolation.

BML-KID-004kidney renalUSA

Blood Urea Nitrogen (BUN)

Q: What does an elevated BUN indicate?

Elevated BUN reflects azotaemia, which may be prerenal (dehydration, heart failure), intrinsic renal (acute tubular necrosis, chronic kidney disease), or postrenal (urinary obstruction). High protein intake, catabolic states, and gastrointestinal bleeding also raise BUN independently of renal injury.

The BUN test measures serum urea nitrogen, a waste product of protein metabolism cleared by glomerular filtration and modulated by tubular reabsorption. It is a dual marker of renal excretory function and effective circulating volume, interpreted with creatinine and the BUN:creatinine ratio to distinguish prerenal, intrinsic renal, and postrenal causes of azotaemia and to guide fluid management.

Biomarkers

Blood (serum)

Sample

2–3 business days

Turnaround

Fasting

What is the BUN test?

The Blood Urea Nitrogen test measures serum urea expressed as its nitrogen content, a waste product cleared by the kidneys that serves as a dual marker of renal function and effective circulating volume. It is a routine component of renal and metabolic panels and is ordered both to assess kidney function and to help classify the cause of azotaemia. BUN is rarely interpreted in isolation. The BUN:creatinine ratio sharpens discrimination between prerenal, intrinsic renal, and postrenal causes of elevated nitrogen waste. Practitioners order BUN to screen for kidney disease, to monitor known renal impairment or potentially nephrotoxic therapy, to assess volume status in acute illness, and to evaluate electrolyte or acid-base disturbances where renal handling is in question. Because urea generation and reabsorption vary with protein intake, catabolic state, and hydration, the result integrates renal and extrarenal physiology.

What does the BUN test measure?

BUN(Blood Urea Nitrogen)

Range: Approximately 7–20 mg/dL (2.5–7.1 mmol/L); age- and hydration-dependent.Optimal: Practitioners often consider a BUN at the lower half of the reference interval (around 10–15 mg/dL) to indicate adequate hydration and normal renal clearance in ambulatory adults, though context — including dietary protein and muscle mass — shapes interpretation.mg/dL / mmol/L

Urea is the principal nitrogenous end-product of protein catabolism, synthesised in the liver from ammonia via the urea cycle and freely filtered by the glomerulus. Approximately half the filtered urea is reabsorbed passively in the proximal tubule, with further reabsorption in the collecting duct when antidiuretic hormone raises tubular permeability. Because reabsorption varies with urine flow and tubular transit time, BUN is sensitive not only to glomerular filtration but also to volume status, dietary protein intake, and the rate of protein catabolism. Its plasma concentration reflects the balance among hepatic synthesis, glomerular filtration, and tubular handling.

BUN is a first-line marker of renal excretory function and volume status. An isolated elevation may be prerenal (volume depletion, heart failure, gastrointestinal bleeding), intrinsic renal (acute or chronic kidney disease), or postrenal (urinary obstruction). When interpreted alongside creatinine — as the BUN:creatinine ratio — prerenal states (ratio typically >20:1) can be distinguished from intrinsic renal injury (ratio closer to 10–15:1). A low BUN suggests overhydration, malnutrition, severe liver disease, or pregnancy. Trends in serial BUN measurements guide fluid management, particularly in hospital and critical-care settings.

Why is the BUN test ordered?

Screening for chronic kidney disease in patients with hypertension, diabetes mellitus, cardiovascular disease, or a family history of renal disease
Evaluation of acute kidney injury in hospitalised or critically ill patients, particularly when prerenal azotaemia from volume depletion is suspected
Baseline and serial monitoring of patients on potentially nephrotoxic medications (aminoglycosides, NSAIDs, ACE inhibitors, lithium, among others)
Assessment of electrolyte disturbances, metabolic acidosis, or unexplained symptoms such as fatigue, anorexia, or altered mentation that may signal uraemia
Work-up of suspected urinary obstruction or postrenal azotaemia, interpreted with imaging and urinalysis
Monitoring of patients with known chronic kidney disease to track disease progression and guide nephrology referral
Investigation of gastrointestinal bleeding, where absorbed blood proteins raise BUN disproportionately to creatinine
Assessment of volume status and fluid management in heart failure, cirrhosis with ascites, or critical illness

Sample collection and turnaround

Sample type

Blood (serum)

Fasting required

Collection method

Venipuncture at patient service centre

Turnaround

2–3 business days

Collection notes

Phlebotomy required. Volume status and recent dietary protein intake can influence the result; note timing in relation to meals or recent intravenous fluid administration when interpreting. Specimen should be separated from cells and analysed promptly or refrigerated.

Specimen requirements

Minimum 0.5 mL serum (gel separator acceptable). Separate from cells within two hours; urea is stable refrigerated for several days. Haemolysed specimens are acceptable for BUN measurement.

What can affect BUN results?

elevatesDietary protein intake

Higher protein intake increases urea production in the liver; low-protein diets or malnutrition reduce BUN independently of renal function.

elevatesVolume depletion and dehydration

Reduced renal perfusion lowers glomerular filtration, and slow tubular flow increases passive urea reabsorption, raising BUN disproportionately to creatinine (prerenal pattern).

elevatesCatabolic states (fever, sepsis, corticosteroid therapy, trauma)

Accelerated protein breakdown increases endogenous urea generation, raising BUN even when renal function is normal.

elevatesGastrointestinal bleeding

Blood in the gut lumen is digested and absorbed as protein, raising urea production; the BUN:creatinine ratio often exceeds 30:1.

reducesOverhydration and excessive intravenous fluids

Dilution and increased glomerular filtration lower BUN; rapid urine flow reduces tubular reabsorption of urea.

reducesSevere liver disease

Impaired hepatic urea-cycle function reduces urea synthesis from ammonia, lowering BUN and potentially masking renal impairment.

What do BUN results mean?

Elevated

Prerenal azotaemia (volume depletion, heart failure, renal artery stenosis), intrinsic renal disease (acute tubular necrosis, glomerulonephritis, interstitial nephritis, chronic kidney disease), postrenal obstruction (urolithiasis, prostatic hypertrophy, tumour), high protein intake, catabolic states, and gastrointestinal bleeding. The BUN:creatinine ratio distinguishes prerenal (typically >20:1) from intrinsic renal causes (10–15:1).

Normal

A normal BUN suggests adequate renal clearance and balanced protein metabolism in the context of normal hydration. It does not exclude early or compensated kidney disease, particularly when creatinine is simultaneously rising or estimated GFR is declining.

Reduced

Overhydration, low dietary protein or malnutrition, severe liver disease (reduced urea synthesis), syndrome of inappropriate antidiuretic hormone secretion (SIADH), and pregnancy. A low BUN is usually not pathological but warrants correlation with clinical context and liver function.

Note: BUN must be interpreted with serum creatinine and the BUN:creatinine ratio to localise azotaemia. Dietary intake, volume status, and catabolic rate all influence the result independently of glomerular filtration, so trends and clinical context matter more than a single isolated value. BUN is not a substitute for direct GFR measurement or cystatin C in precise renal-function assessment.

Frequently asked questions

Both measure renal excretory function, but BUN is influenced by dietary protein, hydration, and catabolism, while creatinine depends more directly on muscle mass and glomerular filtration. The BUN:creatinine ratio helps distinguish prerenal (>20:1) from intrinsic renal (10–15:1) azotaemia.

How to access the BUN test

The BUN reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. (2024)
Lameire NH, et al. Acute kidney injury: an increasing global concern. Lancet. (2013)
Levey AS, et al. Assessment of glomerular filtration rate in health and disease: a state of the art review. Clin Pharmacol Ther. (2017)
National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management. NICE guideline NG203. (2021)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.

Related tests

metabolic diabetes

CMP

The Comprehensive Metabolic Panel is a 14-analyte serum chemistry panel simultaneously evaluating renal function (creatinine, BUN, eGFR), hepatic function (ALT, AST, total bilirubin, albumin, total protein), metabolic status (glucose, calcium), and electrolyte-acid-base homeostasis (sodium, potassium, chloride, bicarbonate) from a single fasting serum specimen.

BML-MET-003View reference →

kidney renal

Cystatin C

The cystatin C test measures serum concentration of a low-molecular-weight protease inhibitor freely filtered by the glomerulus. Unaffected by muscle mass or tubular secretion, it estimates GFR more accurately than creatinine in older adults, children, and patients with altered body composition, detects early filtration loss, and is incorporated into combined eGFR equations to refine CKD staging…

BML-KID-010View reference →